November 16 2007
A new paper, "The effects of hyperbaric
oxygen therapy on oxidative
stress, inflammation, and symptoms in children with autism: an
label pilot study" has just been published in the peer reviewed
medical journal BioMed Central Pediatrics. A pdf of this paper
available for free here
Please go and download the article. If
you want others to also have
the article, I encourage you to send the link as opposed to the
This is important, and here's why. Unlike
traditional titles (such as a New England Journal of Medicine),
it might take two or three years to get essential medical data
published, this particular journal (BioMed Central Pediatrics)
publish more articles based on demand--as measured by pdf downloads.
This is huge because it points a finger at where more research
dollars should be spent.
The primary authors are Dan and Lanier
Rossignol. Dan is an MD and
Lanier is an RN. They are parents of two boys diagnosed with
however, when I last spoke with them, the oldest has improved
tremendously and the youngest is almost completely cured of ASD--
primarily due to HBOT.
Nobody could be more personally motivated
and totally dedicated to
finding a cure for autism than Dan and Lanier Rossignol. Please
support them in their efforts. Based on the evidence, I believe
autism cure will also lead to a cerebral palsy cure.
This paper closely examines the two camps
in hyperbarics. Which
provides greater efficacy 1.3 ATA ambient air or 1.5 ATA with
Also, recent court decisions now require
Georgia Medicaid to
reimburse HBOT, and Georgia Medicaid has no more avenues of appeal.
These decisions can be applied to autistic children as well as
children. This paper further supports Medicaid reimbursement
2948 Windfield Circle
Tucker, GA 30084-6714
To join the discussion
for HBOT, click here
(Free Yahoo account required)
The effects of hyperbaric oxygen therapy
on oxidative stress, inflammation, and symptoms in children with
autism: an open-label pilot study
A pilot study of the effect of Hyperbaric
Oxygen Therapy on autism symptoms, oxidative stress and inflammation
has been published in BMC Pediatrics. In The effects of hyperbaric
oxygen therapy on oxidative stress, inflammation, and symptoms
in children with autism: an open-label pilot study Daniel A Rossignol
, Lanier W Rossignol , S. Jill James , Stepan Melnyk and Elizabeth
Mumper report their findings and conclusions from a study of
18 children with autism aged 3-16 who underwent 40 hyperbaric
sessions of 45 minutes duration each at either 1.5 atmospheres
(atm) and 100% oxygen, or at 1.3 atm and 24% oxygen. On safety
issues the authors report that maximum pressure of 1.5 atm with
up to 100% oxygen was safe and well tolerated. In terms of improvements
the report indicates, as set out in the abstract, that "HBOT
significantly decreased inflammation as measured by CRP levels.
Parental observations support anecdotal
accounts of improvement in several domains of autism." The
authors of the paper note that this was an "open label"
study and "definitive statements regarding the efficacy
of HBOT for the treatment of individuals with autism must await
results from double-blind, controlled trials".